aTyr Pharma, Inc. (ATYR)

aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of $226.63 million. The enterprise value is $174.03 million.

Market Cap	226.63M
Enterprise Value	174.03M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

aTyr Pharma has 75.80 million shares outstanding. The number of shares has increased by 48.50% in one year.

Current Share Class	75.80M
Shares Outstanding	75.80M
Shares Change (YoY)	+48.50%
Shares Change (QoQ)	+4.87%
Owned by Insiders (%)	2.62%
Owned by Institutions (%)	73.84%
Float	68.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.47
P/TBV Ratio	3.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	740.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.41, with a Debt / Equity ratio of 0.21.

Current Ratio	5.41
Quick Ratio	4.80
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -78.14% and return on invested capital (ROIC) is -44.28%.

Return on Equity (ROE)	-78.14%
Return on Assets (ROA)	-39.26%
Return on Capital (ROIC)	-44.28%
Revenue Per Employee	$3,983
Profits Per Employee	-$1.08M
Employee Count	59
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +162.28% in the last 52 weeks. The beta is 1.10, so aTyr Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.10
52-Week Price Change	+162.28%
50-Day Moving Average	2.56
200-Day Moving Average	1.99
Relative Strength Index (RSI)	50.33
Average Volume (20 Days)	877,599

Short Selling Information

The latest short interest is 1.66 million, so 2.19% of the outstanding shares have been sold short.

Short Interest	1.66M
Short Previous Month	1.07M
Short % of Shares Out	2.19%
Short % of Float	2.42%
Short Ratio (days to cover)	1.47

Income Statement

In the last 12 months, aTyr Pharma had revenue of $235,000 and -$63.82 million in losses. Loss per share was -$0.93.

Revenue	235,000
Gross Profit	-54.66M
Operating Income	-68.05M
Pretax Income	-53.93M
Net Income	-63.82M
EBITDA	-67.35M
EBIT	-68.05M
Loss Per Share	-$0.93

Balance Sheet

The company has $65.99 million in cash and $13.57 million in debt, giving a net cash position of $52.42 million or $0.69 per share.

Cash & Cash Equivalents	65.99M
Total Debt	13.57M
Net Cash	52.42M
Net Cash Per Share	$0.69
Equity (Book Value)	65.14M
Book Value Per Share	0.86
Working Capital	62.20M

Cash Flow

In the last 12 months, operating cash flow was -$67.05 million and capital expenditures -$57,000, giving a free cash flow of -$67.11 million.

Operating Cash Flow	-67.05M
Capital Expenditures	-57,000
Free Cash Flow	-67.11M
FCF Per Share	-$0.89

Margins

Gross Margin	n/a
Operating Margin	-28,958.72%
Pretax Margin	-27,155.32%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-9,860.88%

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.50%
Shareholder Yield	-48.50%
Earnings Yield	-28.16%
FCF Yield	-29.61%

Analyst Forecast

The average price target for aTyr Pharma is $19.25, which is 543.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.25
Price Target Difference	543.81%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	315.62%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 1, 2019. It was a reverse split with a ratio of 0.0714285:1.

Last Split Date	Jul 1, 2019
Split Type	Reverse
Split Ratio	0.0714285:1

Scores

aTyr Pharma has an Altman Z-Score of -7.09. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.09
Piotroski F-Score	n/a